Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Oct;41(4):500–504. doi: 10.1136/gut.41.4.500

Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide

W Schwizer 1, J Borovicka 1, P Kunz 1, R Fraser 1, C Kreiss 1, M D'Amato 1, G Crelier 1, P Boesiger 1, M Fried 1
PMCID: PMC1891533  PMID: 9391249

Abstract

Background—Exogenous cholecystokinin (CCK) inhibits antral motility and slows gastric emptying (GE) but the effect of endogenous CCK on the gastric motor mechanisms responsible for GE remains unclear. 
Methods—The effect of the CCK-A antagonist loxiglumide (LOX) on GE and motility was studied using magnetic resonance imaging in six healthy volunteers after ingestion of 500 ml Intralipid 10% (550 kcal). Subjects were studied in the supine position on two occasions during intravenous infusion of LOX (66 µmol/kg/h for 10 min followed by 22 µmol/kg/h) or placebo. GE was determined every 15 minutes using transaxial abdominal scans and motility was studied by means of 120 coronal scans, 1.2 seconds apart. For each coronal image the proximal and distal (antral) diameters were measured at a fixed point in the stomach to determine contraction frequency (ACF) and amplitude (AMP). 
Results—GE was faster during LOX infusion than placebo (t1/2 31 (22) versus 115 (67) minutes, p<0.03). There was little variation in the diameter of the proximal stomach with either LOX or placebo. In the distal stomach marked contractile activity was observed during LOX (ACF 2.9 (0.2) versus 1.5 (2.9) during placebo, p<0.01). AMP also increased during LOX compared with placebo (56 (22)% versus 27 (16)%, p<0.001). 
Conclusion—The increases in antral motility are likely to contribute to the acceleration of GE and suggest that CCK may regulate GE by acting on the distal stomach although an effect on the proximal stomach cannot be excluded. 



Keywords: loxiglumide; magnetic resonance imaging; gastric emptying; gastric motility; antral contraction

Full Text

The Full Text of this article is available as a PDF (114.8 KB).

Figure 1 .

Figure 1

Open in a new tab

: Schematic representation of the experimental design. Every 15 minutes, 30 slices were performed in the transaxial plane to measure gastric emptying, followed immediately by two series of 60 coronal scans (separated by 45 seconds to allow downloading of data) to record gastric motility. 


Figure 2 .

Figure 2

Open in a new tab

: Technique for gastric motility measurements. In each coronal scan, the gastric image outline by contrast was recalled to the computer monitor and a line projected along the longitudinal axis of the stomach. Two lines perpendicular to this were drawn at fixed distances from the orad margin of the stomach and the length of these lines used to measure proximal and distal gastric diameters. 


Figure 3 .

Figure 3

Open in a new tab

: Individual half emptying times showing effect of loxiglumide on gastric emptying of 500 ml 10% Intralipid. 


Figure 4 .

Figure 4

Open in a new tab

: Effect of loxiglumide on the distributions of distal gastric contraction frequency (A) and amplitude (B). 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allescher H. D., Daniel E. E., Fox J. E., Kostolanska F., Rovati L. A. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. J Pharmacol Exp Ther. 1989 Dec;251(3):1134–1141. [PubMed] [Google Scholar]
  2. Azpiroz F., Malagelada J. R. Intestinal control of gastric tone. Am J Physiol. 1985 Oct;249(4 Pt 1):G501–G509. doi: 10.1152/ajpgi.1985.249.4.G501. [DOI] [PubMed] [Google Scholar]
  3. Camilleri M., Brown M. L., Malagelada J. R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986 Jul;91(1):94–99. doi: 10.1016/0016-5085(86)90444-0. [DOI] [PubMed] [Google Scholar]
  4. Camilleri M., Malagelada J. R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest. 1984 Dec;14(6):420–427. doi: 10.1111/j.1365-2362.1984.tb01206.x. [DOI] [PubMed] [Google Scholar]
  5. Fone D. R., Akkermans L. M., Dent J., Horowitz M., van der Schee E. J. Evaluation of patterns of human antral and pyloric motility with an antral wall motion detector. Am J Physiol. 1990 Apr;258(4 Pt 1):G616–G623. doi: 10.1152/ajpgi.1990.258.4.G616. [DOI] [PubMed] [Google Scholar]
  6. Fraser R. J., Horowitz M., Maddox A. F., Dent J. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride. Gut. 1994 Feb;35(2):172–178. doi: 10.1136/gut.35.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fraser R., Fone D., Horowitz M., Dent J. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans. Gut. 1993 Jan;34(1):33–37. doi: 10.1136/gut.34.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fraser R., Shearer T., Fuller J., Horowitz M., Dent J. Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility. Gastroenterology. 1992 Jul;103(1):114–119. doi: 10.1016/0016-5085(92)91103-b. [DOI] [PubMed] [Google Scholar]
  9. Fried M., Erlacher U., Schwizer W., Löchner C., Koerfer J., Beglinger C., Jansen J. B., Lamers C. B., Harder F., Bischof-Delaloye A. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology. 1991 Aug;101(2):503–511. doi: 10.1016/0016-5085(91)90031-f. [DOI] [PubMed] [Google Scholar]
  10. Heddle R., Collins P. J., Dent J., Horowitz M., Read N. W., Chatterton B., Houghton L. A. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol. 1989 Sep-Oct;4(5):437–447. doi: 10.1111/j.1440-1746.1989.tb01741.x. [DOI] [PubMed] [Google Scholar]
  11. Horowitz M., Dent J. Disordered gastric emptying: mechanical basis, assessment and treatment. Baillieres Clin Gastroenterol. 1991 Jun;5(2):371–407. doi: 10.1016/0950-3528(91)90034-x. [DOI] [PubMed] [Google Scholar]
  12. Houghton L. A., Read N. W., Heddle R., Horowitz M., Collins P. J., Chatterton B., Dent J. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology. 1988 Jun;94(6):1285–1291. doi: 10.1016/0016-5085(88)90665-8. [DOI] [PubMed] [Google Scholar]
  13. Kleibeuker J. H., Beekhuis H., Jansen J. B., Piers D. A., Lamers C. B. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man. Eur J Clin Invest. 1988 Apr;18(2):173–177. doi: 10.1111/j.1365-2362.1988.tb02409.x. [DOI] [PubMed] [Google Scholar]
  14. Kuwahara A., Ozawa K., Yanaihara N. Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs. Am J Physiol. 1986 Nov;251(5 Pt 1):G678–G681. doi: 10.1152/ajpgi.1986.251.5.G678. [DOI] [PubMed] [Google Scholar]
  15. Liddle R. A., Morita E. T., Conrad C. K., Williams J. A. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest. 1986 Mar;77(3):992–996. doi: 10.1172/JCI112401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Makovec F., Chistè R., Bani M., Pacini M. A., Setnikar I., Rovati L. A. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittelforschung. 1985;35(7):1048–1051. [PubMed] [Google Scholar]
  17. Mearin F., Camilleri M., Malagelada J. R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986 Jun;90(6):1919–1925. doi: 10.1016/0016-5085(86)90262-3. [DOI] [PubMed] [Google Scholar]
  18. Meyer B. M., Werth B. A., Beglinger C., Hildebrand P., Jansen J. B., Zach D., Rovati L. C., Stalder G. A. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet. 1989 Jul 1;2(8653):12–15. doi: 10.1016/s0140-6736(89)90255-9. [DOI] [PubMed] [Google Scholar]
  19. Read N. W., Houghton L. A. Physiology of gastric emptying and pathophysiology of gastroparesis. Gastroenterol Clin North Am. 1989 Jun;18(2):359–373. [PubMed] [Google Scholar]
  20. Scheurer U., Varga L., Drack E., Bürki H. R., Halter F. Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro. Am J Physiol. 1983 Mar;244(3):G261–G265. doi: 10.1152/ajpgi.1983.244.3.G261. [DOI] [PubMed] [Google Scholar]
  21. Schmidt W. E., Creutzfeldt W., Schleser A., Choudhury A. R., Nustede R., Höcker M., Nitsche R., Sostmann H., Rovati L. C., Fölsch U. R. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol. 1991 Feb;260(2 Pt 1):G197–G206. doi: 10.1152/ajpgi.1991.260.2.G197. [DOI] [PubMed] [Google Scholar]
  22. Schwizer W., Fraser R., Borovicka J., Asal K., Crelier G., Kunz P., Boesiger P., Fried M. Measurement of proximal and distal gastric motility with magnetic resonance imaging. Am J Physiol. 1996 Jul;271(1 Pt 1):G217–G222. doi: 10.1152/ajpgi.1996.271.1.G217. [DOI] [PubMed] [Google Scholar]
  23. Schwizer W., Fraser R., Borovicka J., Crelier G., Boesiger P., Fried M. Measurement of gastric emptying and gastric motility by magnetic resonance imaging (MRI). Dig Dis Sci. 1994 Dec;39(12 Suppl):101S–103S. doi: 10.1007/BF02300384. [DOI] [PubMed] [Google Scholar]
  24. Schwizer W., Fraser R., Maecke H., Siebold K., Funck R., Fried M. Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI. Magn Reson Med. 1994 Apr;31(4):388–393. doi: 10.1002/mrm.1910310407. [DOI] [PubMed] [Google Scholar]
  25. Schwizer W., Maecke H., Fried M. Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology. 1992 Aug;103(2):369–376. doi: 10.1016/0016-5085(92)90823-h. [DOI] [PubMed] [Google Scholar]
  26. Setnikar I., Bani M., Cereda R., Chisté R., Makovec F., Pacini M. A., Revel L. Anticholecystokinin activities of loxiglumide. Arzneimittelforschung. 1987 Oct;37(10):1168–1171. [PubMed] [Google Scholar]
  27. Setnikar I., Bani M., Cereda R., Chisté R., Makovec F., Pacini M. A., Revel L., Rovati L. C., Rovati L. A. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneimittelforschung. 1987 Jun;37(6):703–707. [PubMed] [Google Scholar]
  28. Tougas G., Anvari M., Dent J., Somers S., Richards D., Stevenson G. W. Relation of pyloric motility to pyloric opening and closure in healthy subjects. Gut. 1992 Apr;33(4):466–471. doi: 10.1136/gut.33.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yamagishi T., Debas H. T. Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. Am J Physiol. 1978 Apr;234(4):E375–E378. doi: 10.1152/ajpendo.1978.234.4.E375. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES